A method of genic transfer into an eukaryotic cell through a viral vector
WO2013000974A1
Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity
WO2012107447A2
Culture medium and method for the extraction, isolation and propagation of animal cell lines of high purity and highly purified continuous animal cell lines thus obtained
WO2012042036A1
Method and device for converting time-varying signals acquired over a large number of recording channels
WO2011154505A2
Complex product comprising a cellular carrier and a cytoxic chemotherapeutic drug
WO2011091869A1
Use of low affinity neurotrophin receptor p75 as marker for high differentiation potential muscle stem cells, muscle satellite cells, and degenerative skeletal muscle diseases
US2011010785A1
Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies
